How to optimize the design and implementation of risk prediction tools: focus group with patients with IgA nephropathy

BACKGROUND: IgA nephropathy (IgAN) is a common type of chronic immune-mediated kidney disease with variable risk of progression to end-stage kidney disease. Risk stratification helps clinicians weight the potential risks and benefits of immunosuppressive therapy for individual patients, and can info...

Descripción completa

Detalles Bibliográficos
Autores principales: Gagliardi, Anna R., Reich, Heather N., Cattran, Daniel C., Barbour, Sean J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493917/
https://www.ncbi.nlm.nih.gov/pubmed/32938443
http://dx.doi.org/10.1186/s12911-020-01253-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493917/
https://www.ncbi.nlm.nih.gov/pubmed/32938443
http://dx.doi.org/10.1186/s12911-020-01253-4

Ejemplares similares